Literature DB >> 8977334

Effects of aspirin and Helicobacter pylori on the gastroduodenal mucosal permeability to sucrose.

A A Rabassa1, R Goodgame, F M Sutton, C N Ou, C Rognerud, D Y Graham.   

Abstract

BACKGROUND: A non-invasive marker is needed to identify patients with significant gastrointestinal injury due to non-steroidal anti-inflammatory drugs. Gastrointestinal permeability to sucrose has been suggested as such a test. AIMS: To assess the utility of sucrose permeability as a marker of gastroduodenal mucosal injury after single and multiple doses of aspirin, to identify the site of increased sucrose permeability, to explore the relation between sucrose permeability and endoscopic findings, and to evaluate whether Helicobacter pylori infection influenced gastroduodenal sucrose permeability.
METHODS: After a fasting urine was obtained, 500 ml of a solution containing 100 g of sucrose was ingested. Urine was collected for five hours and assayed for sucrose by high performance liquid chromatography. Sucrose permeability was also assessed 20 minutes after ingestion of 650 mg of aspirin and eight to 12 hours after a 72 hour course of 650 mg aspirin four times a day. The site of increased permeability was identified after pyloric occlusion with a double balloon tube.
RESULTS: Thirty seven healthy volunteers participated. Sucrose permeability (mean (SEM)) increased after both single (195.2 (27) mg and multiple (196.4 (31) mg) doses of aspirin compared with baseline (53.7 (10) mg; p < 0.0005). Balloon pyloric occlusion confirmed that the site of increased sucrose permeability was the stomach. The effect of aspirin on sucrose permeability was similar in those with and without H pylori infection.
CONCLUSION: These results confirm the use of sucrose permeability as a marker of aspirin induced gastroduodenal mucosal injury and identify the stomach as the major site of increased permeability. H pylori infection does not seem to change gastric mucosal sucrose permeability either at baseline or after ingestion of aspirin.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8977334      PMCID: PMC1383291          DOI: 10.1136/gut.39.2.159

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  16 in total

1.  Toward an epidemiology of gastropathy associated with nonsteroidal antiinflammatory drug use.

Authors:  J F Fries; S R Miller; P W Spitz; C A Williams; H B Hubert; D A Bloch
Journal:  Gastroenterology       Date:  1989-02       Impact factor: 22.682

Review 2.  The role of the mucosal barrier in drug-induced gastric ulceration and erosions.

Authors:  A R Cooke
Journal:  Am J Dig Dis       Date:  1976-02

3.  Long-term nonsteroidal anti-inflammatory drug use and gastroduodenal injury: the role of Helicobacter pylori.

Authors:  D S Loeb; N J Talley; D A Ahlquist; H A Carpenter; A R Zinsmeister
Journal:  Gastroenterology       Date:  1992-06       Impact factor: 22.682

4.  Permeability of the human gastric mucosa. Alteration by Acetylsalicylic acid and ethanol.

Authors:  B M Smith; J J Skillman; B G Edwards; W Silen
Journal:  N Engl J Med       Date:  1971-09-23       Impact factor: 91.245

5.  Long-term nonsteroidal antiinflammatory drug use and Helicobacter pylori infection.

Authors:  D Y Graham; M D Lidsky; A M Cox; D J Evans; D G Evans; L Alpert; P D Klein; S L Sessoms; P A Michaletz; Z A Saeed
Journal:  Gastroenterology       Date:  1991-06       Impact factor: 22.682

6.  Interrelationships between Helicobacter pylori infection, nonsteroidal antiinflammatory drugs and gastroduodenal disease. A prospective study in healthy volunteers.

Authors:  A V Thillainayagam; S Tabaqchali; S J Warrington; M J Farthing
Journal:  Dig Dis Sci       Date:  1994-05       Impact factor: 3.199

7.  Effect of several drugs on gastric potential difference in man.

Authors:  H S Murray; M P Strottman; A R Cooke
Journal:  Br Med J       Date:  1974-01-05

8.  Gastric adaptation occurs with aspirin administration in man.

Authors:  D Y Graham; J L Smith; S M Dobbs
Journal:  Dig Dis Sci       Date:  1983-01       Impact factor: 3.199

9.  A simple, non-invasive marker of gastric damage: sucrose permeability.

Authors:  L R Sutherland; M Verhoef; J L Wallace; G Van Rosendaal; R Crutcher; J B Meddings
Journal:  Lancet       Date:  1994-04-23       Impact factor: 79.321

10.  Sucrose: a novel permeability marker for gastroduodenal disease.

Authors:  J B Meddings; L R Sutherland; N I Byles; J L Wallace
Journal:  Gastroenterology       Date:  1993-06       Impact factor: 22.682

View more
  7 in total

1.  Pathogenesis of increased sucrose permeability in H. pylori gastritis.

Authors:  D Y Graham
Journal:  Dig Dis Sci       Date:  2000-05       Impact factor: 3.199

2.  Significance of a novel sucrose permeability test using serum in the diagnosis of early gastric cancer.

Authors:  Tadayuki Shishido; Taketo Yamaguchi; Takeo Odaka; Masanori Seimiya; Hiromitsu Saisho; Fumio Nomura
Journal:  World J Gastroenterol       Date:  2005-11-28       Impact factor: 5.742

3.  Helicobacter pylori activates myosin light-chain kinase to disrupt claudin-4 and claudin-5 and increase epithelial permeability.

Authors:  Jason P Fedwick; Tamia K Lapointe; Jonathan B Meddings; Philip M Sherman; Andre G Buret
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

4.  Effects of aspirin on gastroduodenal permeability in alcoholics and controls.

Authors:  Ashkan Farhadi; Ali Keshavarzian; Mary J Kwasny; Maliha Shaikh; Louis Fogg; Cynthia Lau; Jeremy Z Fields; Christopher B Forsyth
Journal:  Alcohol       Date:  2010-07-03       Impact factor: 2.405

5.  Changes of tight junction and interleukin-8 expression using a human gastroid monolayer model of Helicobacter pylori infection.

Authors:  Takahiro Uotani; Kosuke Murakami; Tomohisa Uchida; Shingo Tanaka; Hiroyuki Nagashima; Xi-Lei Zeng; Junko Akada; Mary K Estes; David Y Graham; Yoshio Yamaoka
Journal:  Helicobacter       Date:  2019-04-05       Impact factor: 5.753

Review 6.  Helicobacter pylori in intensive care: why we should be interested.

Authors:  Megan S Robertson; Robert L Clancy; John F Cade
Journal:  Intensive Care Med       Date:  2003-08-28       Impact factor: 17.440

Review 7.  Intestinal permeability in a patient with liver cirrhosis.

Authors:  Jonathan Manuel Aguirre Valadez; Liliana Rivera-Espinosa; Osvely Méndez-Guerrero; Juan Luis Chávez-Pacheco; Ignacio García Juárez; Aldo Torre
Journal:  Ther Clin Risk Manag       Date:  2016-11-18       Impact factor: 2.423

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.